We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Type 2 Diabetes Caused by Low Vitamin D Disputed

By LabMedica International staff writers
Posted on 16 Oct 2014
Low circulating concentrations of 25-hydroxyvitamin D (25[OH]D), a marker of vitamin D status, are associated with an increased risk of type 2 diabetes, but whether this association is causal remains equivocal.

A Mendelian randomization approach has been used to estimate the, causal association between 25(OH)D concentration and risk of type 2 diabetes by analysis using single nucleotide polymorphisms (SNPs) within or near four genes related to 25(OH)D synthesis and metabolism.

Scientists at the University of Cambridge (UK) used several data sources from populations of European descent. More...
Associations of SNPs with risk of type 2 diabetes were based on 28,144 cases of type 2 diabetes and 76,344 non-cases from a case-cohort study. Apart from a few studies, all studies ascertained type 2 diabetes cases through biochemical testing, such as concentrations of fasting glucose, two-hour glucose, or HbA1c.

SNPs were assayed by the Illumina 660 quad-chip or the Metabochip (Illumina; Little Chesterford, UK). The assays used 10 ng of genomic DNA in a 2.5 μL reaction volume, 384-well plate with a G-Storm GS4 Thermal Cycler (Genetic Research Instrumentation (GRI); Rayne, UK). Endpoint detection and allele calling were done with an ABI PRISM 7900HT Sequence Detection System (Applied Biosystems; Paisley, UK). The authors also used circulating 25(OH)D levels, considered the best indicator of vitamin D status, as the measure for vitamin D. Insufficiency was defined as having blood levels of 25(OH)D under 50 nmol/L.

The scientists found no evidence of a link between the risk of developing type 2 diabetes and the different gene variants that control blood levels of vitamin D. They also found no links between varying levels of vitamin D and several features of type 2 diabetes, such as glucose and glycated hemoglobin, and neither did they find evidence that low vitamin D causes the disease. The authors concluded that their findings suggest that interventions to reduce the risk of type 2 diabetes by increasing concentrations of 25(OH)D are not currently justified. The study was published on October 1, 2014, in the journal the Lancet Diabetes & Endocrinology.

Related Links:

University of Cambridge
Illumina
Genetic Research Instrumentation




Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Manual Pipetting Aid
Pipette Controllers macro
New
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Unlike conventional molecular methods, VedaBio\'s CRISPR-based technology detects targets without requiring amplification (Photo courtesy of Veda Bio)

Target-Amplification-Free CRISPR Platform Demonstrates Molecular Detection in Under 10 Minutes

Molecular testing plays an important role in clinical diagnostics, but conventional workflows often require time-consuming procedures and specialized equipment, limiting their use outside centralized laboratories.... Read more

Immunology

view channel
Image: The panel expands Cepheid’s respiratory testing portfolio on the GeneXpert platform, offering laboratories greater flexibility in selecting tests based on clinical needs. (Photo courtesy of Cepheid)

Multiplex PCR Test Gains CE Marking to Support Respiratory Infection Diagnosis

Acute respiratory infections often present with overlapping symptoms, making it difficult to distinguish between viral and bacterial causes. Seasonal surges of influenza-like illness in Europe further... Read more

Microbiology

view channel
Image: Malaria is caused by Plasmodium parasites, primarily transmitted through the bites of infected female Anopheles mosquitoes (Image Credit: Adobe Stock)

Complete Malaria Genomes Could Improve Species Identification and Surveillance

Malaria remains a major global health challenge, with an estimated 282 million cases and 610,000 deaths worldwide in 2024. Although most research has focused on Plasmodium falciparum, Plasmodium ovale... Read more

Industry

view channel
Image: The TOMR trial uses Signatera-guided MRD testing to identify high-risk patients for curative-intent treatment.

Natera and Incyte Collaborate on MRD-Guided Colorectal Cancer Treatment Study

Natera (Austin, TX, USA) has entered into a clinical collaboration with Incyte (Wilmington, DE, USA) for a Phase II study evaluating molecular residual disease (MRD)-guided treatment in colorectal cancer.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.